We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Monoclonal Antibodies Specific to Mycoplasma genitalium Available

By LabMedica International staff writers
Posted on 12 Jul 2012
A set of four monoclonal antibodies that are specific to Mycoplasma genitalium has been released. More...
They do not cross react with other Mycloplasmas and/or related bacteria.

The antibodies function in the enzyme-linked immunosorbent assay (ELISA) and indirect fluorescence assay (IFA) and are available for research and assay development.

Mycoplasma genitalium is a small bacterium without a cell wall. It resides in the human urogenital tract where it obtains its nutrients and causes urethritis in males and females as well as pelvic inflammatory disease (PID) in females.

ViroStat (Portland, ME, USA) released the four monoclonal antibodies. These may be used for assay development but meanwhile they are not yet available for diagnostic purposes. The data sheet, including pricing, for the antibodies can be found at the ViroStat website.

ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies. These include high affinity antibodies to Flu A, Flu B, Respiratory syncytial virus (RSV) and Streptococcus A for use in rapid lateral flow devices as well as antibodies to food-borne pathogens and toxins. Also, many specificities to Hepatitis C virus (HCV), Hepatitis B virus (HBV), Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) are available for use in antiviral high-throughput screening assays (HTS) assays.

Related Links:

ViroStat



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.